Below is a detailed analysis of the quarterly data for Arfin India Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
For Sales, as of Mar 2025, the value is 153.37 Cr.. The value appears to be declining and may need further review. It has decreased from 180.37 Cr. (Dec 2024) to 153.37 Cr., marking a decrease of 27.00 Cr..
For Expenses, as of Mar 2025, the value is 146.78 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 169.43 Cr. (Dec 2024) to 146.78 Cr., marking a decrease of 22.65 Cr..
For Operating Profit, as of Mar 2025, the value is 6.59 Cr.. The value appears to be declining and may need further review. It has decreased from 10.94 Cr. (Dec 2024) to 6.59 Cr., marking a decrease of 4.35 Cr..
For OPM %, as of Mar 2025, the value is 4.30%. The value appears to be declining and may need further review. It has decreased from 6.07% (Dec 2024) to 4.30%, marking a decrease of 1.77%.
For Other Income, as of Mar 2025, the value is 1.33 Cr.. The value appears strong and on an upward trend. It has increased from 0.14 Cr. (Dec 2024) to 1.33 Cr., marking an increase of 1.19 Cr..
For Interest, as of Mar 2025, the value is 4.62 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 5.56 Cr. (Dec 2024) to 4.62 Cr., marking a decrease of 0.94 Cr..
For Depreciation, as of Mar 2025, the value is 1.02 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 1.02 Cr..
For Profit before tax, as of Mar 2025, the value is 2.28 Cr.. The value appears to be declining and may need further review. It has decreased from 4.50 Cr. (Dec 2024) to 2.28 Cr., marking a decrease of 2.22 Cr..
For Tax %, as of Mar 2025, the value is 76.32%. The value appears to be increasing, which may not be favorable. It has increased from 32.67% (Dec 2024) to 76.32%, marking an increase of 43.65%.
For Net Profit, as of Mar 2025, the value is 0.54 Cr.. The value appears to be declining and may need further review. It has decreased from 3.03 Cr. (Dec 2024) to 0.54 Cr., marking a decrease of 2.49 Cr..
For EPS in Rs, as of Mar 2025, the value is 0.03. The value appears to be declining and may need further review. It has decreased from 0.18 (Dec 2024) to 0.03, marking a decrease of 0.15.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
×
Quarterly Chart
Profit & Loss - Annual Report
Last Updated: June 16, 2025, 2:55 pm
Metric
Mar 2014
Mar 2015
Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
213
250
286
363
466
413
359
303
526
544
535
616
Expenses
207
238
271
336
421
390
364
287
502
518
505
579
Operating Profit
6
12
15
27
45
23
-6
16
24
26
30
36
OPM %
3%
5%
5%
8%
10%
6%
-2%
5%
5%
5%
6%
6%
Other Income
0
1
1
0
1
0
2
2
2
2
2
2
Interest
2
5
5
6
10
12
14
11
12
14
19
20
Depreciation
0
1
1
1
2
2
3
3
3
4
4
4
Profit before tax
4
7
10
20
34
10
-21
5
10
11
10
14
Tax %
34%
34%
34%
36%
36%
34%
5%
12%
6%
6%
15%
36%
Net Profit
3
5
7
13
22
7
-22
4
9
10
8
9
EPS in Rs
0.24
0.43
0.61
0.89
1.37
0.41
-1.36
0.25
0.58
0.65
0.52
0.54
Dividend Payout %
0%
6%
7%
6%
12%
0%
0%
0%
0%
0%
0%
0%
×
Profit & Loss Yearly Chart
YoY Net Profit Growth
Year
2014-2015
2015-2016
2016-2017
2017-2018
2018-2019
2019-2020
2020-2021
2021-2022
2022-2023
2023-2024
2024-2025
YoY Net Profit Growth (%)
66.67%
40.00%
85.71%
69.23%
-68.18%
-414.29%
118.18%
125.00%
11.11%
-20.00%
12.50%
Change in YoY Net Profit Growth (%)
0.00%
-26.67%
45.71%
-16.48%
-137.41%
-346.10%
532.47%
6.82%
-113.89%
-31.11%
32.50%
Arfin India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
Compounded Sales Growth
10 Years:
9%
5 Years:
11%
3 Years:
5%
TTM:
15%
Compounded Profit Growth
10 Years:
7%
5 Years:
19%
3 Years:
0%
TTM:
11%
Stock Price CAGR
10 Years:
29%
5 Years:
48%
3 Years:
16%
1 Year:
-41%
Return on Equity
10 Years:
9%
5 Years:
9%
3 Years:
9%
Last Year:
7%
Last Updated: Unknown
No data available for the Balance Sheet data table.
Reserves and Borrowings Chart
Cash Flow
Month
Month
Mar 2014
Mar 2015
Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Cash from Operating Activity +
-12
6
-2
-22
-10
13
23
11
11
29
5
-21
Cash from Investing Activity +
-1
-5
-4
-7
-20
-17
-6
0
-3
-8
-4
-9
Cash from Financing Activity +
12
1
6
29
30
4
-18
-12
-8
-14
-8
30
Net Cash Flow
-2
2
0
0
-0
-0
0
-0
0
7
-7
0
Free Cash Flow Chart
Financial Efficiency Indicators
Month
Mar 2013
Mar 2014
Mar 2015
Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Debtor Days
55
60
34
42
59
59
44
32
51
51
38
36
Inventory Days
30
58
75
95
92
79
114
121
168
84
89
124
Days Payable
50
58
60
71
46
21
21
23
72
44
49
55
Cash Conversion Cycle
35
61
48
66
105
117
138
129
147
91
78
105
Working Capital Days
38
60
50
58
88
101
120
109
140
89
84
102
ROCE %
24%
15%
24%
25%
29%
30%
12%
-4%
8%
12%
13%
14%
Financial Efficiency Indicators Chart
Share Holding Pattern
Month
Mar 2022
Jun 2022
Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Promoters
74.11%
74.11%
74.11%
74.11%
74.11%
74.11%
74.11%
74.09%
74.09%
69.79%
69.79%
69.79%
FIIs
1.78%
1.90%
0.00%
0.00%
0.00%
0.00%
0.95%
2.56%
2.56%
2.41%
2.41%
2.41%
Government
0.04%
0.04%
0.04%
0.04%
0.04%
0.08%
0.08%
0.08%
0.08%
0.07%
0.07%
0.19%
Public
24.07%
23.95%
25.85%
25.85%
25.86%
25.80%
24.86%
23.27%
23.26%
27.73%
27.73%
27.60%
No. of Shareholders
2,370
2,347
3,953
5,382
5,213
5,155
5,400
5,633
6,281
7,112
7,997
8,392
Shareholding Pattern Chart
No. of Shareholders
This stock is not held by any mutual fund.
ROCE Trend
EPS Trend
Key Financial Ratios
Month
Mar 25
FaceValue
1.00
Basic EPS (Rs.)
0.54
Diluted EPS (Rs.)
0.54
Cash EPS (Rs.)
0.78
Book Value[Excl.RevalReserv]/Share (Rs.)
9.29
Book Value[Incl.RevalReserv]/Share (Rs.)
9.29
Revenue From Operations / Share (Rs.)
36.50
PBDIT / Share (Rs.)
2.27
PBIT / Share (Rs.)
2.03
PBT / Share (Rs.)
0.85
Net Profit / Share (Rs.)
0.54
NP After MI And SOA / Share (Rs.)
0.54
PBDIT Margin (%)
6.21
PBIT Margin (%)
5.55
PBT Margin (%)
2.33
Net Profit Margin (%)
1.48
NP After MI And SOA Margin (%)
1.48
Return on Networth / Equity (%)
5.83
Return on Capital Employeed (%)
18.44
Return On Assets (%)
2.65
Long Term Debt / Equity (X)
0.14
Total Debt / Equity (X)
0.74
Current Ratio (X)
1.74
Quick Ratio (X)
0.58
Interest Coverage Ratio (X)
1.93
Interest Coverage Ratio (Post Tax) (X)
1.46
Enterprise Value (Cr.)
571.10
EV / Net Operating Revenue (X)
0.92
EV / EBITDA (X)
14.93
MarketCap / Net Operating Revenue (X)
0.74
Price / BV (X)
2.93
Price / Net Operating Revenue (X)
0.74
EarningsYield
0.01
After reviewing the key financial ratios for Arfin India Ltd, here is a detailed analysis based on the latest available data and recent trends:
For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. No previous period data is available for comparison.
For Basic EPS (Rs.), as of Mar 25, the value is 0.54. This value is below the healthy minimum of 5. No previous period data is available for comparison.
For Diluted EPS (Rs.), as of Mar 25, the value is 0.54. This value is below the healthy minimum of 5. No previous period data is available for comparison.
For Cash EPS (Rs.), as of Mar 25, the value is 0.78. This value is below the healthy minimum of 3. No previous period data is available for comparison.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 9.29. No previous period data is available for comparison.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 9.29. No previous period data is available for comparison.
For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 36.50. No previous period data is available for comparison.
For PBDIT / Share (Rs.), as of Mar 25, the value is 2.27. This value is within the healthy range. No previous period data is available for comparison.
For PBIT / Share (Rs.), as of Mar 25, the value is 2.03. This value is within the healthy range. No previous period data is available for comparison.
For PBT / Share (Rs.), as of Mar 25, the value is 0.85. This value is within the healthy range. No previous period data is available for comparison.
For Net Profit / Share (Rs.), as of Mar 25, the value is 0.54. This value is below the healthy minimum of 2. No previous period data is available for comparison.
For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.54. This value is below the healthy minimum of 2. No previous period data is available for comparison.
For PBDIT Margin (%), as of Mar 25, the value is 6.21. This value is below the healthy minimum of 10. No previous period data is available for comparison.
For PBIT Margin (%), as of Mar 25, the value is 5.55. This value is below the healthy minimum of 10. No previous period data is available for comparison.
For PBT Margin (%), as of Mar 25, the value is 2.33. This value is below the healthy minimum of 10. No previous period data is available for comparison.
For Net Profit Margin (%), as of Mar 25, the value is 1.48. This value is below the healthy minimum of 5. No previous period data is available for comparison.
For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.48. This value is below the healthy minimum of 8. No previous period data is available for comparison.
For Return on Networth / Equity (%), as of Mar 25, the value is 5.83. This value is below the healthy minimum of 15. No previous period data is available for comparison.
For Return on Capital Employeed (%), as of Mar 25, the value is 18.44. This value is within the healthy range. No previous period data is available for comparison.
For Return On Assets (%), as of Mar 25, the value is 2.65. This value is below the healthy minimum of 5. No previous period data is available for comparison.
For Long Term Debt / Equity (X), as of Mar 25, the value is 0.14. This value is below the healthy minimum of 0.2. No previous period data is available for comparison.
For Total Debt / Equity (X), as of Mar 25, the value is 0.74. This value is within the healthy range. No previous period data is available for comparison.
For Current Ratio (X), as of Mar 25, the value is 1.74. This value is within the healthy range. No previous period data is available for comparison.
For Quick Ratio (X), as of Mar 25, the value is 0.58. This value is below the healthy minimum of 1. No previous period data is available for comparison.
For Interest Coverage Ratio (X), as of Mar 25, the value is 1.93. This value is below the healthy minimum of 3. No previous period data is available for comparison.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.46. This value is below the healthy minimum of 3. No previous period data is available for comparison.
For Enterprise Value (Cr.), as of Mar 25, the value is 571.10. No previous period data is available for comparison.
For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.92. This value is below the healthy minimum of 1. No previous period data is available for comparison.
For EV / EBITDA (X), as of Mar 25, the value is 14.93. This value is within the healthy range. No previous period data is available for comparison.
For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 1. No previous period data is available for comparison.
For Price / BV (X), as of Mar 25, the value is 2.93. This value is within the healthy range. No previous period data is available for comparison.
For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 1. No previous period data is available for comparison.
For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. No previous period data is available for comparison.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
×
Profitability Ratios (%)
Liquidity Ratios
Liquidity Ratios (%)
Interest Coverage Ratios (%)
Valuation Ratios
Fair Value
Fair Value of Arfin India Ltd as of July 7, 2025 is: 26.09
Calculation basis:
Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.
As of July 7, 2025, Arfin India Ltd is Undervalued by 1.12% compared to the current share price 25.80
Intrinsic Value of Arfin India Ltd as of July 7, 2025 is: 30.43
Calculation basis:
Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.
This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.
As of July 7, 2025, Arfin India Ltd is Undervalued by 17.95% compared to the current share price 25.80
Last 5 Year EPS CAGR: 16.65%
*Investments are subject to market risks
Strength and Weakness
Unable to fetch valid data for stock valuation.
Stock Analysis
Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Arfin India Ltd:
Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
ROE%: 5.83% (Industry Average ROE: 8.36%)
ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
Stock P/E: 47.6 (Industry average Stock P/E: 49.07)
Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
Total Debt / Equity: 0.74
Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions. Stock Rating:
About the Company - Qualitative Analysis
Arfin India Ltd. is a Public Limited Listed company incorporated on 10/04/1992 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L65990GJ1992PLC017460 and registration number is 017460. Currently Company is involved in the business activities of Manufacture of basic precious and other non-ferrous metals. Company's Total Operating Revenue is Rs. 615.75 Cr. and Equity Capital is Rs. 16.87 Cr. for the Year ended 31/03/2025.
FAQ: Stock data is invalid or not in the correct format.
Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Arfin India Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
